Finance

Lists
Why is 9969 down 7.87%?
Dive Deeper
9969:HKG
InnoCare Pharma Ltd
HK$14.51
-7.87%
(-1.24) 1D
Sep 24, 4:08:29 PM GMT+8  ·   HKD
All symbols
SymbolPriceChange% Change
Generating top insights for 9969...
Open
HK$15.98
High
HK$16.16
Low
HK$13.93
Mkt. cap
31.19B
Avg. vol.
8.41M
Volume
30.23M
P/E ratio
33.00
52-wk high
HK$20.18
52-wk low
HK$9.65
EPS
HK$0.44
No. of employees
1K
Open
HK$15.98
High
HK$16.16
Low
HK$13.93
Mkt. cap
31.19B
Avg. vol.
8.41M
Volume
30.23M
P/E ratio
33.00
52-wk high
HK$20.18
52-wk low
HK$9.65
EPS
HK$0.44
No. of employees
1K
News stories
From web sources and news partners
About InnoCare Pharma Ltd
CEOJasmine Cui
Employees1.39K
FoundedNov 3, 2015
Headquarters-
SectorBiotechnology
Websiteinnocarepharma.com
Last report
Aug 24, 2026
Fiscal period
Q2 2026
EPS / Est. (CNY)
- / -
Revenue / Est. (CNY)
608.43M / 617.31M
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in CNY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CNY
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
383.89M
1.26B
528.63M
608.43M
Cost of goods sold
48.46M
66.11M
62.72M
56.27M
Cost of revenue
48.46M
66.11M
62.72M
56.27M
Research and development expenses
226.35M
275.57M
229.16M
267.92M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
187.93M
243.50M
162.45M
205.62M
Operating expense
388.22M
560.08M
392.10M
476.27M
Total operating expenses
436.68M
626.19M
454.82M
532.54M
Operating income
-52.79M
633.39M
73.81M
75.89M
Other non operating income
26.02M
-26.67M
11.13M
-13.40M
EBT including unusual items
-33.60M
719.92M
104.85M
142.30M
EBT excluding unusual items
-8.17M
673.62M
101.24M
102.50M
Income tax expense
2.72M
3.79M
2.40M
5.07M
Effective tax rate
-8.09%
0.53%
2.29%
3.57%
Other operating expenses
-25.90M
40.29M
-320.57K
3.37M
Net income
-34.32M
706.88M
105.82M
140.54M
Net profit margin
-8.94%
56.12%
20.02%
23.10%
Earnings per share
-
-
-
-
Interest and investment income
44.67M
47.46M
30.69M
37.25M
Interest expense
-14.49M
-12.42M
-14.38M
-15.13M
Net interest expenses
30.17M
35.04M
16.30M
22.12M
Depreciation and amortization charges
-
-
-
-
EBITDA
-36.03M
652.95M
93.37M
94.23M
Gain or loss from assets sale
3.40K
-3.40K
-
-197.23K
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps